Dynamiker Biotechnology (Tianjin) Co (BJSE:920009) WACC %:10.67% (As of Aug. 19, 2026) — 81% Above Median

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BJSE:920009 Dynamiker Biotechnology (Tianjin) Co Ltd BJSE:920009
46 GF Score
Price ¥36.71
! 3 Warning Signs
View Full Analysis

What is Dynamiker Biotechnology (Tianjin) Co WACC %?

Dynamiker Biotechnology (Tianjin) Co BJSE:920009 46 WACC % is 10.67% as of Aug. 19, 2026, which is 81% above its 10-year median of 5.89. GuruFocus rates BJSE:920009 with a GF Score™ of 46/100. The stock has 3 warning signs investors should review. Among 1,019 Drug Manufacturers companies, Dynamiker Biotechnology (Tianjin) Co ranks worse than 68.4% on this metric.

As of today (2026-08-19), Dynamiker Biotechnology (Tianjin) Co's weighted average cost of capital is 10.67%%. Dynamiker Biotechnology (Tianjin) Co's ROIC % is 23.32% (calculated using TTM income statement data). Dynamiker Biotechnology (Tianjin) Co generates higher returns on investment than it costs the company to raise the capital needed for that investment. It is earning excess returns. A firm that expects to continue generating positive excess returns on new investments in the future will see its value increase as growth increases.

*Note: The beta of this company cannot be obtained because it has a price history shorter than 3 years. It will thus be set to 1 as default to calculate WACC.

For a comprehensive WACC calculation, please access the WACC Calculator.


Dynamiker Biotechnology (Tianjin) Co  (BJSE:920009) WACC % Explanation

Because it costs money to raise capital. A firm that generates higher ROIC % than it costs the company to raise the capital needed for that investment is earning excess returns. A firm that expects to continue generating positive excess returns on new investments in the future will see its value increase as growth increases, whereas a firm that earns returns that do not match up to its cost of capital will destroy value as it grows.

As of today, Dynamiker Biotechnology (Tianjin) Co's weighted average cost of capital is 10.67%%. Dynamiker Biotechnology (Tianjin) Co's ROIC % is 23.32% (calculated using TTM income statement data). Dynamiker Biotechnology (Tianjin) Co generates higher returns on investment than it costs the company to raise the capital needed for that investment. It is earning excess returns. A firm that expects to continue generating positive excess returns on new investments in the future will see its value increase as growth increases.

*Note: The beta of this company cannot be obtained because it has a price history shorter than 3 years. It will thus be set to 1 as default to calculate WACC.


Be Aware

1. GuruFocus uses book value of debt (D) to do the calculation. It is simplified by adding latest one-year quarterly average Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation together.
For companies that report quarterly, GuruFocus combines all of the most recent year's quarterly debt data from the beginning of the year to the year-end and calculates the average.
For companies that report semi-annually, GuruFocus combines all of the most recent year's semi-annual debt data from the start of the year to the year-end and calculates the average.
For companies that report annually, GuruFocus combines the beginning and ending annual debt data from the most recent year and then calculates the average.

2. The WACC formula discussed above does not include Preferred Stock. Please adjust if preferred stock is considered.

3. (Expected Return of the Market - Risk-Free Rate of Return) is also called market premium. GuruFocus requires market premium to be 6%.

4. GuruFocus uses the latest TTM Interest Expense divided by the latest one-year quarterly average debt to get the simplified cost of debt.


Related Terms

Dynamiker Biotechnology (Tianjin) Co WACC % Historical Data

* Premium members only.

The historical data trend for Dynamiker Biotechnology (Tianjin) Co's WACC % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Dynamiker Biotechnology (Tianjin) Co WACC % Chart

Dynamiker Biotechnology (Tianjin) Co Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
WACC %
Get a 7-Day Free Trial Premium Member Only 0.00 0.00 1.61 0.00 10.16

Dynamiker Biotechnology (Tianjin) Co Quarterly Data
Dec18 Dec19 Jun20 Dec20 Dec21 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
WACC % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.36 4.23 8.46 10.16 10.30

BJSE:920009 vs LLY, JNJ, ABBV: WACC % Comparison

For the Drug Manufacturers - General subindustry, Dynamiker Biotechnology (Tianjin) Co's WACC %, along with its competitors' market caps and WACC % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Dynamiker Biotechnology (Tianjin) Co WACC % vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Dynamiker Biotechnology (Tianjin) Co's WACC % distribution charts can be found below:

* The bar in red indicates where Dynamiker Biotechnology (Tianjin) Co's WACC % falls into.


BJSE:920009
46GF Score
Dynamiker Biotechnology (Tianjin) Co Ltd BJSE:920009
WACC % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Dynamiker Biotechnology (Tianjin) Co WACC % Calculation

The weighted average cost of capital (WACC) is the rate that a company is expected to pay on average to all its security holders to finance its assets. The WACC is commonly referred to as the firm's cost of capital. Generally speaking, a company's assets are financed by debt and equity. WACC is the average of the costs of these sources of financing, each of which is weighted by its respective use in the given situation. By taking a weighted average, we can see how much interest the company has to pay for every dollar it finances.

WACC=E/(E + D)*Cost of Equity+D/(E + D)*Cost of Debt*(1 - Tax Rate)

1. Weights:
Generally speaking, a company's assets are financed by debt and equity. We need to calculate the weight of equity and the weight of debt.
The market value of equity (E) is also called "Market Cap". As of today, Dynamiker Biotechnology (Tianjin) Co's market capitalization (E) is ¥2846.714 Mil.
The market value of debt is typically difficult to calculate, therefore, GuruFocus uses book value of debt (D) to do the calculation. It is simplified by adding the latest one-year quarterly average Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation together. As of Mar. 2026, Dynamiker Biotechnology (Tianjin) Co's latest one-year quarterly average Book Value of Debt (D) is ¥2.6363 Mil.
a) weight of equity = E / (E + D) = 2846.714 / (2846.714 + 2.6363) = 0.9991
b) weight of debt = D / (E + D) = 2.6363 / (2846.714 + 2.6363) = 0.0009

2. Cost of Equity:
GuruFocus uses Capital Asset Pricing Model (CAPM) to calculate the required rate of return. The formula is:
Cost of Equity = Risk-Free Rate of Return + Beta of Asset * (Expected Return of the Market - Risk-Free Rate of Return)
a) GuruFocus uses 10-Year Treasury Constant Maturity Rate as the risk-free rate. It is updated daily. The current risk-free rate is 4.672%. Please go to Economic Indicators page for more information. Please note that we use the 10-Year Treasury Constant Maturity Rate of the country/region where the company is headquartered. If the data for that country/region is not available, then we will use the 10-Year Treasury Constant Maturity Rate of the United States as default.
b) Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. Dynamiker Biotechnology (Tianjin) Co's beta cannot be obtained because it has a price history shorter than 3 years. It will thus be set to 1 as default to calculate WACC.
c) (Expected Return of the Market - Risk-Free Rate of Return) is also called market premium. GuruFocus requires market premium to be 6%.
Cost of Equity = 4.672% + 1 * 6% = 10.672%

3. Cost of Debt:
GuruFocus uses latest TTM Interest Expense divided by the latest one-year quarterly average debt to get the simplified cost of debt.
As of Mar. 2026, Dynamiker Biotechnology (Tianjin) Co's interest expense (positive number) was ¥0.308 Mil. Its total Book Value of Debt (D) is ¥2.6363 Mil.
Cost of Debt = 0.308 / 2.6363 = 11.683%.

4. Multiply by one minus TTM Tax Rate:
GuruFocus uses the most recent TTM Tax Expense divided by the most recent TTM Pre-Tax Income to calculate the tax rate. The calculated TTM tax rate is limited to between 0% and 100%. If the calculated tax rate is higher than 100%, it is set to 100%. If the calculated tax rate is less than 0%, it is set to 0%.
The latest calculated TTM Tax Rate = 4.448 / 100.646 = 4.42%.

Dynamiker Biotechnology (Tianjin) Co's Weighted Average Cost Of Capital (WACC) for Today is calculated as:

WACC=E / (E + D)*Cost of Equity+D / (E + D)*Cost of Debt*(1 - Tax Rate)
=0.9991*10.672%+0.0009*11.683%*(1 - 4.42%)
=10.67%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about WACC % →
What does a WACC % of 10.67% mean?
Dynamiker Biotechnology (Tianjin) Co (BJSE:920009) has a WACC % of 10.67% as of Aug. 19, 2026. The weighted average cost of capital (WACC) is the average rate a company pays to finance assets. View historical data on Dynamiker Biotechnology (Tianjin) Co and its competitors. This is 81% above median its historical median of 5.89. Over the past decade, Dynamiker Biotechnology (Tianjin) Co's WACC % has ranged from 1.61 to 10.69. According to the industry distribution chart, Dynamiker Biotechnology (Tianjin) Co ranks #697 out of 1019 companies in the Drug Manufacturers industry, placing it in the top 68.4%.
Is Dynamiker Biotechnology (Tianjin) Co's WACC % too high?
Dynamiker Biotechnology (Tianjin) Co's current WACC % of 10.67% is 81% above median its 10-year median of 5.89. Over the past 10 years, this metric has ranged from a low of 1.61 to a high of 10.69. The Drug Manufacturers industry median WACC % is 8.82. Dynamiker Biotechnology (Tianjin) Co's value of 10.67% is 21% above this industry median. Based on the distribution chart, Dynamiker Biotechnology (Tianjin) Co ranks #697 out of 1019 companies in the Drug Manufacturers industry, which is below the industry midpoint. Overall, Dynamiker Biotechnology (Tianjin) Co has a GF Score™ of 46/100, reflecting its overall financial health beyond just this single metric.
How does Dynamiker Biotechnology (Tianjin) Co's WACC % compare to LLY and JNJ?
According to the Drug Manufacturers industry distribution chart, Dynamiker Biotechnology (Tianjin) Co ranks #697 out of 1019 companies for WACC %. This places Dynamiker Biotechnology (Tianjin) Co in the lower half of its industry. The industry median WACC % is 8.82. Dynamiker Biotechnology (Tianjin) Co's value of 10.67% is 21% above this benchmark. Historically, Dynamiker Biotechnology (Tianjin) Co's own WACC % has ranged from 1.61 to 10.69 over the past decade. While the company's 10-year median is 5.89 vs. the industry median of 8.82, Dynamiker Biotechnology (Tianjin) Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good WACC % for a Drug Manufacturers company?
The median WACC % among Drug Manufacturers companies is 8.82, based on 1,019 companies in the industry. Companies in the top quartile (top 25%) have a WACC % significantly above this median, while those in the bottom quartile fall well below. However, WACC % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Dynamiker Biotechnology (Tianjin) Co's current WACC % of 10.67% is 21% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high WACC % mean?
A high WACC % can signal that a stock is expensive relative to its fundamentals. The weighted average cost of capital (WACC) is the average rate a company pays to finance assets. View historical data on Dynamiker Biotechnology (Tianjin) Co and its competitors. For the Drug Manufacturers industry, the median WACC % is 8.82 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Dynamiker Biotechnology (Tianjin) Co's current WACC % is 10.67%, which is 81% above median its own 10-year median of 5.89. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Dynamiker Biotechnology (Tianjin) Co stock overvalued right now?
Dynamiker Biotechnology (Tianjin) Co (BJSE:920009) has a current WACC % of 10.67%. The current WACC % is 10.67%, which is 81% above median its 10-year median of 5.89 and 21% above the Drug Manufacturers industry median of 8.82. Dynamiker Biotechnology (Tianjin) Co's overall GF Score™ is 46/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is WACC % calculated?
WACC % is calculated from a company's financial statements. For Dynamiker Biotechnology (Tianjin) Co (BJSE:920009), the current WACC % is 10.67% as of Aug. 19, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Dynamiker Biotechnology (Tianjin) Co Business Description

Address No. 3667 Zhongbin Avenue, Building 2, Rongzhi Industrial Park, China-Singapore Eco-City, Tianjin Binhai New Area, Tianjin, CHN, 300467
Dynamiker Biotechnology (Tianjin) Co Ltd specializes in R&D, production, and sales of early serological diagnosis of invasive mycosis and in vitro diagnostic products for other pathogenic microorganisms.
46GF Score

Get the complete analysis for BJSE:920009

WACC % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

¥36.71
Price